PeerView Immunology & Transplantation CME/CNE/CPE Audio Podcast

PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.

http://ww2.peerview.com

Eine durchschnittliche Folge dieses Podcasts dauert 50m. Bisher sind 332 Folge(n) erschienen. Dieser Podcast erscheint alle 5 Tage.

Gesamtlänge aller Episoden: 11 days 20 hours 8 minutes

subscribe
share






Boni Elizabeth Elewski, MD, Mark Lebwohl, MD - Novel Targets for Management of Generalized Pustular Psoriasis: Utilizing a Team-Based Approach From Diagnosis to Treatment of Flares


Go online to PeerView.com/NJA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 September 21, 2023  58m
 
 

Ruben A. Mesa, MD, FACP - Taking the Targeted Option for Myelofibrosis: Insights on Modern JAKi Platforms and Emerging Therapeutics


Go online to PeerView.com/YJX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 August 8, 2023  1h0m
 
 

Robert Z. Orlowski, MD, PhD - The New ABCs of Myeloma Care: Enhancing Outcomes With CD38 Antibodies, BCMA Immunotherapy, and Unique Bispecific Platforms


Go online to PeerView.com/HZN860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 July 29, 2023  1h56m
 
 

Shmuel Shoham, MD / Ghady Haidar, MD - What’s New, and What’s Next? Customizing COVID-19 Prevention Approaches in Transplant Patients to Increase Uptake, Access, and Efficacy


Go online to PeerView.com/ERY860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 July 1, 2023  57m
 
 

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, Zahra Mahmoudjafari, PharmD, MBA, BCOP - Coordinating Better Outcomes in Multiple Myeloma: Pharmacist Leadership With Novel Antibodies and CAR-T Therapy


Go online to PeerView.com/NDY860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 June 2, 2023  1h4m
 
 
share








 June 2, 2023  30m
 
 

Jennifer Wargo, MD, MMSc - Harnessing the Power of Immunotherapy in Resectable Melanoma: Guidance for Delivering Effective Adjuvant and Neoadjuvant Strategies


Go online to PeerView.com/NHA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 April 27, 2023  1h4m
 
 

Naval Daver, MD, Joseph D. Khoury, MD, FCAP - The Precision Team in AML: Exploring Pathologist-Informed Clinical Decisions in Challenging AML Settings


Go online to PeerView.com/XSA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 April 14, 2023  1h30m
 
 

Stephanie Lee, MD, MPH - Overcoming GVHD Is the Key to Better HCT Outcomes: Guidance on Managing Acute and Chronic Disease


Go online to PeerView.com/CJR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 April 7, 2023  54m
 
 

Aaron T. Gerds, MD, MS / John Mascarenhas, MD - Shaping Modern Management of Myelofibrosis: Guidance on the Conjunction of Targeted Therapy and AlloHCT


Go online to PeerView.com/SDA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 April 5, 2023  59m